Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-01-20 @ 9:55 PM
Study NCT ID:
NCT06862869
Status:
RECRUITING
Last Update Posted:
2025-12-12
First Post:
2025-02-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Sponsor:
Organization: